# Autonomy Bio Inc. — Form D

Autonomy Bio Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-27. The offering totals $17.0M, of which $17.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-03-27
- Form: D
- Accession: 0002063071-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.0M
- Amount sold: $17.0M
- Investors: 8
- Date of first sale: 2025-03-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-542291

## Issuer

- Name: Autonomy Bio Inc.
- CIK: 0002063071
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 512 2ND STREET, SAN FRANCISCO, CA, 94107
- Phone: 207-730-0982

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Alex Colville | Director | San Francisco, CA |
| Alex Colville | Executive Officer | San Francisco, CA |

## More

- [CIK 2063071 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2063071&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002063071-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.